clinical laboratory

British scientist wins NYSCF Robertson Stem Cell Prize Professor Peter J.

British scientist wins NYSCF – Robertson Stem Cell Prize Professor Peter J. Coffey’s stem cell therapy for age-related macular degeneration expected to begin clinical trials in 2012The New York Stem Cell Base announced today a British stem cell scientist attempting to cure blindness would be the first recipient of The New York Stem Cell Foundation – Robertson Prize in Stem Cell Study, a $200,000 prize awarded for extraordinary achievement in translational stem cell research annually . The award shall go to Professor Peter J. Coffey, DPhil, Director of the London Task to Remedy Blindness and Professor of Cellular Therapy and Visual Sciences at the Institute of Ophthalmology in London, for his pioneering function in the usage of human embryonic stem cells to get rid of Age-Related Macular Degeneration , a common form of blindness. Continue reading

ArroHealth included in Inc.

The Inc. 5000's aggregate revenue is $205 billion, generating 647,000 jobs over the past three years.. ArroHealth included in Inc. Magazine’s list of fastest-growing private companies in the U.S. ArroHealth, a full-service company of risk adjustment and HEDIS services for health plans and provider groupings, has been called to Inc. Magazine's 34th annual Inc. 5000, an exclusive rank of the fastest-growing private businesses in the U.S. ArroHealth's significant revenue growth in the last 4 years qualified it for the distinguished list. We are honored to be included in this list of highly successful businesses, stated Glen Moller, ArroHealth's CEO. Continue reading